Ignite Creation Date:
2025-12-24 @ 10:23 PM
Ignite Modification Date:
2026-01-31 @ 5:45 PM
Study NCT ID:
NCT01303835
Status:
COMPLETED
Last Update Posted:
2015-07-17
First Post:
2011-02-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Low Dose Naltrexone for Glioma Patients
Sponsor:
Katy Peters
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Pro00027661
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None